Your Article Summary
Teva Announces Approval and Launch of Tri-Lo Sprintec Tablets
Teva Pharmaceutical Industries, 07/02/09
Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application to market a generic version of Ortho McNeil Janssen's oral contraceptive, Ortho Tri-Cyclen Lo. Shipment of this product, for which Teva's trade name is Tri-Lo Sprintec, has commenced.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
I-Flow Announces Availability of ON-Q SilverDressings
Wounds, 10/09/09
Medical Devices: How Do You Know They Are Safe
AMN Healthcare, 10/12/09
Avodart (dutasteride) Regulatory Update
GlaxoSmithKline, 10/02/09
Article Search
Sponsor


See Latest Articles


